Clinical study about adjuvant.
Phase 3
- Conditions
- cataract or retina vitreous disease and others.
- Registration Number
- JPRN-jRCTs041180066
- Lead Sponsor
- Horiguchi Masayuki
- Brief Summary
The triamcinolone acetonide-assisted phacoemulsification procedure is safe and useful for visualizing the posterior surface of the lens nucleus and facilitates removal of the lens nucleus by phacoemulsification.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 250
Inclusion Criteria
The patient who was enough explained and understand this study.
The patient who agree this study by the free will and sign consent forms.
The patient who was diagnosed adjuvant is appropriate.
Exclusion Criteria
The patient who judged adjuvant is inappropriate by principal investigator or member of a research project.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method visual acuity
- Secondary Outcome Measures
Name Time Method surgery time<br>complication<br>intraocular pressure<br>electroretinogram study<br>specular microscope study<br>Laser flare cell meter study<br>optical coherence tomography study